Nocturne Acquisition Corp (MBTC) has released an update.
Nocturne Acquisition Corporation has announced the postponement of its Extraordinary General Meeting, initially set for January 30, 2024, to February 27, 2024, to vote on a merger with Cognos Therapeutics. The meeting, which will be held virtually, aims to gather shareholder proxies in support of the business combination. This move is part of a strategic effort to strengthen the company’s future financial and operational performance, with details and further information provided in the definitive Registration Statement available to shareholders and on the SEC’s website.
For further insights into MBTC stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.